欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/2868/002
药品名称Augmentan Filmtabletten 875/125 mg
活性成分
    • amoxicillin trihydrate 1004.31 mg
    • clavulanic acid 125.0 mg
剂型Film-coated tablet
上市许可持有人GlaxoSmithKline GmbH & Co. KG Prinzregentenplatz 9 81675 München Germany
参考成员国 - 产品名称Germany (DE)
Augmentan Filmtabletten 875/125 mg
互认成员国 - 产品名称
    • Portugal (PT)
    • Austria (AT)
      Augmentin 1 g (875 mg/125 mg) Filmtabletten
    • Belgium (BE)
    • Bulgaria (BG)
    • Cyprus (CY)
    • Czechia (CZ)
    • Greece (GR)
    • Spain (ES)
    • Hungary (HU)
      AUGMENTIN DUO 875 mg/125 mg filmtabletta
    • Ireland (IE)
    • Italy (IT)
    • Lithuania (LT)
      Augmentin 875mg/125mg plėvele dengtos tabletės
    • Luxembourg (LU)
    • Latvia (LV)
      Augmentin 875 mg/125 mg apvalkotās tabletes
    • Malta (MT)
    • Poland (PL)
      Augmentin
    • Romania (RO)
      Augmentin 875 mg/125 mg comprimate filmate
    • Slovakia (SK)
      Augmentin 1 g
    • Slovenia (SI)
    • United Kingdom (Northern Ireland) (XI)
    • Estonia (EE)
许可日期2010/07/09
最近更新日期2024/03/15
药物ATC编码
    • J01CR02 amoxicillin and beta-lactamase inhibitor
申请类型
  • TypeLevel1:New Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Full Dossier Art 8.3(i) Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase